Snapshots Saudi Arabia Pharmaceuticals 2010Mintel - SnapshotsOctober 27, 2010 15 Pages - SKU: SNAP2847449 |
Additional Information
Scope- Market Size by Value
- Market Segmentation
- Market Segmentation by Value
- Market Shares
- Market Shares by Value
- Market Forecast
- Market Forecast by Value
- Spimaco
- GlaxoSmithKline
- Pfizer
- Tabuk
- Jamjoom Pharma
- Julphar
- Novartis
- Glaxo Saudi Arabia
- AstraZeneca
- Bayer Schering PH
More Prescription Drugs reports by Mintel - Snapshots
Pharmaceuticals – Czech Republic – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Czech Republic by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers ...
Pharmaceuticals – Slovak Republic – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Slovak Republic by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers ...
Pharmaceuticals – US – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...
Pharmaceuticals – Venezuela – a snapshot (2011) by Mintel - Snapshots
See all reports like this >>Pharmaceuticals in Venezuela by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...
More Saudi Arabia Prescription Drugs reports
Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: Favourable demographic and epidemiological trends and the expansion of the country’shealthcare services will continue to underpin the development of Saudi Arabia\s pharmaceutical marketvalues. ...
Calming and Sleeping in Saudi Arabia by Euromonitor International
The government did little to prevent UTC sales of Rx medicines in most product areas during the review period, with most chemists/pharmacies selling Rx products ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: Saudi Arabia’s transition to an increasingly privatised and comprehensive healthcare systemwill drive the demand for both patented and generic drugs. The country is ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2012 by Business Monitor International
See all reports like this >>BMI View: The Saudi Arabian government said it will increase its healthcare budget for 2012 by 26%. Though BMI remains slightly more conservative in ...
More Saudi Arabia reports
D&B Country RiskLine Report: Saudi Arabia by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
2007 Saudi Arabia Industry & Market Outlook by Barnes Reports
See all reports like this >>The 2007 Saudi Arabia Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Saudi Arabia and 500+ ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Prescription Drugs Reports
